Clinical Trial Update: Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating genetic testing in Noonan syndrome patients who were previously treated with Norditropin, as an extension of a prior …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noonan Syndrome

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Genetic Disorder, Noonan Syndrome | Phase 3 | Status: COMPLETED